Age-specific reference ranges for serum prostate-specific antigen in black men

New England Journal of Medicine

Volumn 335, Issue 5, 1996, Pages 304-310

  Morgan, Ted O ^a   Jacobsen, Steven J ^b   Mccarthy, William F ^c   Jacobson, Debra J ^b   Mcleod, David G ^a,c   Moul, Judd W ^a,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE VALUE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0029830551     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608013350502     Document Type: Article

References (21)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27
2. Morton RA Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994;44.637-45.
3. Mettlin C, Joncs G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin 1993;43:42-6.
4. Early detection of prostate cancer and use of transrectal ultrasound. In: American Urological Association 1992 policy statement book. Baltimore: American Urological Association, 1992:4.20.
5. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
6. Walsh PC. Using prostate-specific antigen to diagnose prostate cancer: sailing in uncharted waters. Ann Intern Med 1993;119:948-9.
7. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90.
8. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993;270:860-4.
9. Dalkin BL, Ahmann FR, Kopp JB. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma. J Urol 1993;150:1837-9.
10. Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E. Age-specific reference ranges for serum prostate-specific antigen. Urology 1995; 46:54-7.
11. DeAntoni EP, Crawford ED. Prostate cancer awareness week: education, service, and research in a community setting. Cancer 1995;75:Suppl: 1874-9.
12. el-Galley RES, Petros JA, Sanders WH, et al. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. Urology 1995;46:200-4.
13. Oestcrling JE, Kumamoto Y, Tsukamoto T, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995;75:347-53.
14. Moul JW, Sesterhenn IA, Connelly RR, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 1995;274:1277-81.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tricounty area, 1973 to 1987. Urology 1995;45:93-102.
17. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
18. Sakr WA, Crignon DJ, Haas GP. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract 1995;191:838-41.
19. Ross RK, Bernstein L, Lobo RA, et al. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992;339:887-9.
20. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571-4.
21. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.